Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
| Actual shortage: | 226 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-07-15 | 2022-08-12 | 164741 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-09 | 2023-01-06 | 177603 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178757 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185013 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-04-14 | 2023-08-04 | 189644 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210662 |
| APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212922 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-12-22 | 2024-02-09 | 214244 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225002 |
| APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2024-04-26 | 2024-05-24 | 226333 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154181 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2023-08-12 | 2023-10-27 | 201707 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-07-17 | 2017-08-18 | 15959 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2019-01-30 | 2019-02-01 | 74022 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2020-10-28 | 2020-11-02 | 127367 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-01 | 2022-09-15 | 168418 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2023-06-29 | 2024-01-19 | 196946 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2017-12-14 | 2018-02-15 | 32813 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2018-05-31 | 2018-10-05 | 50956 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |